129 related articles for article (PubMed ID: 36030657)
21. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
22. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
[TBL] [Abstract][Full Text] [Related]
23. R-spondin-3 induces secretory, antimicrobial Lgr5
Sigal M; Reinés MDM; Müllerke S; Fischer C; Kapalczynska M; Berger H; Bakker ERM; Mollenkopf HJ; Rothenberg ME; Wiedenmann B; Sauer S; Meyer TF
Nat Cell Biol; 2019 Jul; 21(7):812-823. PubMed ID: 31235935
[TBL] [Abstract][Full Text] [Related]
24. Leucine-rich repeat-containing G-protein coupled receptor 5/GPR49 activates G12/13-Rho GTPase pathway.
Kwon MS; Park BO; Kim HM; Kim S
Mol Cells; 2013 Sep; 36(3):267-72. PubMed ID: 23912594
[TBL] [Abstract][Full Text] [Related]
25. The spatial distribution of LGR5+ cells correlates with gastric cancer progression.
Simon E; Petke D; Böger C; Behrens HM; Warneke V; Ebert M; Röcken C
PLoS One; 2012; 7(4):e35486. PubMed ID: 22530031
[TBL] [Abstract][Full Text] [Related]
26. LncRNA CASC15 promotes colon cancer cell proliferation and metastasis by regulating the miR‑4310/LGR5/Wnt/β‑catenin signaling pathway.
Jing N; Huang T; Guo H; Yang J; Li M; Chen Z; Zhang Y
Mol Med Rep; 2018 Aug; 18(2):2269-2276. PubMed ID: 29956772
[TBL] [Abstract][Full Text] [Related]
27. Gastric Lgr5(+) stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice.
Li XB; Yang G; Zhu L; Tang YL; Zhang C; Ju Z; Yang X; Teng Y
Cell Res; 2016 Jul; 26(7):838-49. PubMed ID: 27091432
[TBL] [Abstract][Full Text] [Related]
28. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
[TBL] [Abstract][Full Text] [Related]
29. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
[TBL] [Abstract][Full Text] [Related]
30. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
Hou MF; Chen PM; Chu PY
BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
[TBL] [Abstract][Full Text] [Related]
31. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
Liu L; Tian YC; Mao G; Zhang YG; Han L
Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
[TBL] [Abstract][Full Text] [Related]
32. PROX1 Was Associated with LGR5 and Wnt Signaling and Contributed to Poor Prognosis in Gastric Cancer.
Nakazawa N; Sohda M; Ide M; Shimoda Y; Tateno K; Watanabe T; Sano A; Sakai M; Yokobori T; Ogawa H; Oyama T; Shirabe K; Saeki H
Oncology; 2022; 100(11):569-575. PubMed ID: 36103842
[TBL] [Abstract][Full Text] [Related]
33. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
34. Exploiting the Receptor-Binding Domains of R-Spondin 1 to Target Leucine-Rich Repeat-Containin G-Coupled Protein Receptor 5-Expressing Stem Cells in Ovarian Cancer.
Wong C; Mulero MC; Barth EI; Wang K; Shang X; Tikle S; Rice C; Gately D; Howell SB
J Pharmacol Exp Ther; 2023 May; 385(2):95-105. PubMed ID: 36849411
[TBL] [Abstract][Full Text] [Related]
35. LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.
Vieira GC; Chockalingam S; Melegh Z; Greenhough A; Malik S; Szemes M; Park JH; Kaidi A; Zhou L; Catchpoole D; Morgan R; Bates DO; Gabb PD; Malik K
Oncotarget; 2015 Nov; 6(37):40053-67. PubMed ID: 26517508
[TBL] [Abstract][Full Text] [Related]
36. Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression.
Jang BG; Kim HS; Chang WY; Bae JM; Kim WH; Kang GH
Am J Pathol; 2018 Oct; 188(10):2236-2250. PubMed ID: 30036518
[TBL] [Abstract][Full Text] [Related]
37. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
38. Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach.
Leushacke M; Tan SH; Wong A; Swathi Y; Hajamohideen A; Tan LT; Goh J; Wong E; Denil SLIJ; Murakami K; Barker N
Nat Cell Biol; 2017 Jul; 19(7):774-786. PubMed ID: 28581476
[TBL] [Abstract][Full Text] [Related]
39. Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A.
Mi L; Lei L; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J; Yin F
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766708
[TBL] [Abstract][Full Text] [Related]
40. Invasive mouse gastric adenocarcinomas arising from Lgr5+ stem cells are dependent on crosstalk between the Hedgehog/GLI2 and mTOR pathways.
Syu LJ; Zhao X; Zhang Y; Grachtchouk M; Demitrack E; Ermilov A; Wilbert DM; Zheng X; Kaatz A; Greenson JK; Gumucio DL; Merchant JL; di Magliano MP; Samuelson LC; Dlugosz AA
Oncotarget; 2016 Mar; 7(9):10255-70. PubMed ID: 26859571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
